Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD)

• by Ye Li, Xiangyu Fu, Ling Huang, Lirong Xiao, Danian Chen

• April 24, 2026

Supplying Ocular Nutritional Supplements

Supplying ocular nutritional supplements (ONS) is a way to deepen patient trust and improve their visual outcomes, with the byproduct a new revenue stream. This is the theme of this issue of Optometric Management. 

• by Neda Gioia, OD, CNS, IFMCP, FOWNS

• January 1, 2026

• 6 min

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

• by Andrea Surnit

• April 20, 2026

• 2 min

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

• by Kerri Miller

• March 24, 2026

• 2 min